08.08.2023 12:50:33
|
Eli Lilly And Co. Q2 Profit Increases, beats estimates
(RTTNews) - Eli Lilly And Co. (LLY) announced a profit for its second quarter that increased from the same period last year and beat the Street estimates.
The company's earnings came in at $1.76 billion, or $1.95 per share. This compares with $952.5 million, or $1.05 per share, in last year's second quarter.
Excluding items, Eli Lilly And Co. reported adjusted earnings of $1.90 billion or $2.11 per share for the period.
Analysts on average had expected the company to earn $1.98 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 28.0% to $8.31 billion from $6.49 billion last year.
Eli Lilly And Co. earnings at a glance (GAAP) :
-Earnings (Q2): $1.76 Bln. vs. $952.5 Mln. last year. -EPS (Q2): $1.95 vs. $1.05 last year. -Analyst Estimate: $1.98 -Revenue (Q2): $8.31 Bln vs. $6.49 Bln last year.
-Guidance: Full year EPS guidance: $9.70 - $9.90 Full year revenue guidance: $33.4 - $33.9 Bln
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
22.01.25 |
Erste Schätzungen: Eli Lilly stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
21.01.25 |
S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Eli Lilly-Investment von vor 5 Jahren abgeworfen (finanzen.at) | |
17.01.25 |
Aufschläge in New York: S&P 500 klettert zum Handelsende (finanzen.at) | |
17.01.25 |
Börse New York in Grün: S&P 500 nachmittags stärker (finanzen.at) | |
17.01.25 |
Starker Wochentag in New York: S&P 500 klettert mittags (finanzen.at) | |
14.01.25 |
NYSE-Handel: S&P 500 notiert zum Handelsende im Plus (finanzen.at) | |
14.01.25 |
Eli Lilly-Aktie sackt ab: Wachstum 2024 nicht so stark wie erhofft (dpa-AFX) | |
14.01.25 |
Dienstagshandel in New York: S&P 500 am Dienstagnachmittag in der Gewinnzone (finanzen.at) |
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 785,60 | 1,59% |